Client News
NOXXON to present latest clinical data from NOX-A12 / KEYTRUDA® combination trial at the 2019 AACR Annual Meeting
Newron Supports Global Rare Disease Day® 2019
Ergomed and PSR Orphan Experts, Ergomed’s rare disease specialist division, announce 2019 activities in support of Rare Disease Day®
Medigene AG: Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis
InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum
NOXXON files application for Phase ½ clinical trial combining NOX-A12 & radiotherapy for the treatment of brain cancer patients
Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers
Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update